glp-1 binge eating GLP-1s & 💊, Eating disorders, including binge eating disorder, are a contraindication for medications. Yet many people are still accessing them privately., During eating-disorder GLP-1 for Binge Eating Disorder:

Imbalances in GABAergic (inhibitory) and glutamatergic (excitatory) neurotransmission amplify aberrant neural firing patterns

Est prohibida en deportes

However, when combined, their synergistic effects are amplified, making them a formidable force against gut dysbiosis

However, to maximise these benefits and ensure safety, it's essential to be aware of certain precautions

*Average weight loss based on 68 and 72 week clinical trials studying semaglutide (2.4 mg) and tirzepatide (10-15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related health condition, the average weight loss was 15% and 20% respectively